Literature DB >> 9211565

Cinitapride protects against ethanol-induced gastric mucosal injury in rats: role of 5-hydroxytryptamine, prostaglandins and sulfhydryl compounds.

C Alarcón-de-la-Lastra Romero1, A López, M J Martín, C la Casa, V Motilva.   

Abstract

This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol. Results were compared with those for 5-hydroxytryptamine (5-HT: 10 mg kg-1). The possible involvements of gastric mucus secretion, endogenous prostaglandins (PGs) and sulfhydryl compounds (SH) in the protection mediated by CNT were also examined. Intraperitoneal administration of CNT (0.50 and 1 mg kg-1), 30 min before ethanol, significantly prevented gastric ulceration and increased the hexosamine content of gastric mucus. CNT (1 mg kg-1) also produced a significant increase in gastric mucosal levels of PGE2, but did not induce any significant changes in SH values. On the contrary, pretreatment with 5-HT worsened ethanol-induced erosions, however, did not affect gastric mucus secretion, glycoprotein content or PGE2 levels, although the non-protein SH fraction was significantly decreased. The present results demonstrate that the gastroprotective effects of CNT could be partly explained by a complex PG dependent mechanism. We suggest that 5-HT dependent mechanisms through 5-HT2 receptor blockade and 5-HT1 receptor activation could be also involved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211565     DOI: 10.1159/000139487

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  6 in total

1.  Gastric toxicity of racemic ketoprofen and its enantiomers in rat: oxygen radical generation and COX-expression.

Authors:  C Alarcón de la Lastra; A Nieto; M J Martín; F Cabré; J M Herrerías; V Motilva
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

2.  Increased expression of tight junction protein occludin is associated with the protective effect of mosapride against aspirin-induced gastric injury.

Authors:  Chenchen Liu; Zhaotao Duan; Yue Guan; Hailu Wu; Kewei Hu; Xin Gao; Fangcen Yuan; Zongdan Jiang; Ye Fan; Bangshun He; Shukui Wang; Zhenyu Zhang
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

3.  The 5-HT4 receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage.

Authors:  Masahiko Fujisawa; Takahisa Murata; Masatoshi Hori; Hiroshi Ozaki
Journal:  J Gastroenterol       Date:  2009-12-10       Impact factor: 7.527

4.  Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa: comparison with acetaminophen and diclofenac.

Authors:  Susana Sánchez; M José Martín; Pablo Ortiz; Virginia Motilva; Catalina Alarcón de la Lastra
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

5.  Inferring drug-disease associations based on known protein complexes.

Authors:  Liang Yu; Jianbin Huang; Zhixin Ma; Jing Zhang; Yapeng Zou; Lin Gao
Journal:  BMC Med Genomics       Date:  2015-05-29       Impact factor: 3.063

Review 6.  A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery.

Authors:  Thanigaimalai Pillaiyar; Sangeetha Meenakshisundaram; Manoj Manickam; Murugesan Sankaranarayanan
Journal:  Eur J Med Chem       Date:  2020-04-02       Impact factor: 6.514

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.